Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256879 | SCV001433371 | uncertain significance | Conduction disorder of the heart | 2019-04-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003145497 | SCV003829524 | uncertain significance | not provided | 2019-11-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003770334 | SCV004696895 | uncertain significance | Duchenne muscular dystrophy | 2023-11-17 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 535 of the DMD protein (p.Val535Ile). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 978344). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |